Head to Head Contrast: Tenon Medical (NASDAQ:TNON) versus Daxor (NASDAQ:DXR)

Tenon Medical (NASDAQ:TNON) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current recommendations and price targets for Tenon Medical and Daxor, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	0	0	2	0	3.00
Daxor	0	0	1	0	3.00

Tenon Medical presently has a consensus target price of $5.50, suggesting a potential upside of 358.33%. Daxor has a consensus target price of $25.00, suggesting a potential upside of 227.23%. Given Tenon Medical’s higher probable upside, equities research analysts clearly believe Tenon Medical is more favorable than Daxor.

Risk & Volatility

Tenon Medical has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.06, suggesting that its share price is 106% less volatile than the S&P 500.

Profitability

This table compares Tenon Medical and Daxor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-413.88%	-1,785.88%	-164.26%
Daxor	N/A	N/A	N/A

Insider and Institutional Ownership

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 4.7% of Tenon Medical shares are owned by insiders. Comparatively, 59.0% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Tenon Medical and Daxor”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.32 million	1.14	-$15.58 million	($27.23)	-0.04
Daxor	$2.13 million	17.34	N/A	N/A	N/A

Daxor has lower revenue, but higher earnings than Tenon Medical.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.